Butantan's new vaccine facility is behind schedule. Photo: Govesp
Construction works for a new facility built by the Butantan Biological Institute to produce the CoronaVac Covid-19 vaccine have missed the deadline initially announced by the São Paulo state government. It remains unclear when the facility will be ready.
The initial timetable set a deadline of September 30 for the conclusion of construction works, but the facility remains unfinished. Finance newspaper Valor noted that neither Butantan nor Comunitas — the non-profit organization hired to manage the project — provided a specific deadline for the conclusion.
The factory is being built in an unfinished space initially designated for the production of hemoderivatives. Its conversion into a vaccine factory was funded by BRL 189 million (USD 35 million) in company donations.
While the facility is invaluable for public health in the region — with the Butantan Institute willing to export the jabs to Latin America — it is also an important political project. São Paulo Governor João Doria expected to have the first jabs produced as early as December, in time for the start of the 2022 electoral campaign.
Panama was once a part of Colombia. Its canal, a monumental engineering achievement of its…
The specialization trend among corporate board members It is not only a matter of perception:…
Panama will hold its presidential elections on Sunday, months after huge protests saw thousands descend…
The city of Rio de Janeiro estimates that a Madonna concert this Saturday on Copacabana…
Latin America’s trend of banning opposition candidates from elections has caught on in an ever-growing…
The São Paulo City Council on Thursday approved legislation authorizing Brazil’s largest city to sign…